Literature DB >> 2861763

Vecuronium and d-tubocurarine combination: potentiation of effect.

R K Mirakhur, F M Gibson, C J Ferres.   

Abstract

To evaluate possible potentiation of neuromuscular blocking effect of a combination of vecuronium and d-tubocurarine, cumulative dose-response curves were constructed to compare the potency of this combination with vecuronium and d-tubocurarine given alone. Ten patients each were given incremental injections of 80 micrograms/kg d-tubocurarine or 5 micrograms/kg vecuronium plus 40 micrograms/kg d-tubocurarine, the data for incremental administration of 10 micrograms/kg vecuronium being used from our previously published study (7). The results showed the combination of vecuronium plus d-tubocurarine to be significantly more potent (P less than 0.05) than would be expected from a simple additive effect of the individual drugs given alone. The ED95 doses of d-tubocurarine and vecuronium were 530 micrograms/kg and 57 micrograms/kg, respectively, when administered alone, but when administered together, the ED95 doses were 160 and 20 micrograms/kg, respectively.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2861763

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  5 in total

1.  Interactions between ORG9426 and other non-depolarizing neuromuscular blocking agents in rats in vivo.

Authors:  K Watanabe
Journal:  J Anesth       Date:  1992-07       Impact factor: 2.078

2.  Nondepolarizing neuromuscular blocking drugs and train-of-four fade.

Authors:  E P McCoy; F M Connolly; R K Mirakhur; P B Loan; L D Paxton
Journal:  Can J Anaesth       Date:  1995-03       Impact factor: 5.063

3.  Mivacurium infusion requirements following vecuronium: different response between adults and children.

Authors:  W Denman; N Goudsouzian
Journal:  Can J Anaesth       Date:  1995-07       Impact factor: 5.063

Review 4.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

5.  Synergy between pairs of competitive antagonists at adult human muscle acetylcholine receptors.

Authors:  Man Liu; James P Dilger
Journal:  Anesth Analg       Date:  2008-08       Impact factor: 5.108

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.